title: Generic sirolimus: a future opportunity to decrease the cost of oncology care?
authors.forename: Laurence H
authors.initials: LH
authors.lastname: Baker
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D016568:Drugs, Generic / Q000191:economics* / Q000627:therapeutic use; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use; D054973:Perivascular Epithelioid Cell Neoplasms / Q000188:drug therapy / Q000191:economics*; D015398:Signal Transduction / Q000187:drug effects; D020123:Sirolimus / Q000191:economics* / Q000627:therapeutic use; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D016568:Drugs, Generic; D007166:Immunosuppressive Agents; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus